about
Changes in metabolic risk factors over 10 years and their associations with late-life cognitive performance: The Multi-Ethnic Study of Atherosclerosis.Genome-wide scan of copy number variation in late-onset Alzheimer's disease.Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County StudyCommunity engagement in diverse populations for Alzheimer disease prevention trials.A comparison of neuropsychological performance between US and Russia: preparing for a global clinical trial.Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County StudyA homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in agingHormone therapy and Alzheimer disease dementia: new findings from the Cache County Study.Effects of cardiovascular medications on rate of functional decline in Alzheimer disease.Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache County StudyCerebrovascular smooth muscle actin is increased in nondemented subjects with frequent senile plaques at autopsy: implications for the pathogenesis of Alzheimer disease.Pre-clinical cognitive phenotypes for Alzheimer disease: a latent profile approach.Phenotypic regional functional imaging patterns during memory encoding in mild cognitive impairment and Alzheimer's disease.The association between an inflammatory diet and global cognitive function and incident dementia in older women: The Women's Health Initiative Memory Study.Conversion to dementia from mild cognitive disorder: the Cache County Study.Epidemiology of cognitive aging and Alzheimer's disease: contributions of the cache county utah study of memory, health and aging.Characteristics of a two-stage screen for incident dementia.Modifying dementia risk and trajectories of cognitive decline in aging: the Cache County Memory Study.Self- or proxy-reported stroke and the risk of Alzheimer disease.Risk of mortality with vitamin E supplements: the Cache County studyMore evidence for the benefits of cognitive activity over the lifespanRelationship of Lipids and Lipid-Lowering Medications With Cognitive Function: The Multi-Ethnic Study of AtherosclerosisInvestigating Predictors of Cognitive Decline Using Machine LearningCognitive resilience among APOE ε4 carriers in the oldest oldSex-Related Differences in Brain Volumes and Cerebral Blood Flow Among Overweight and Obese Adults With Type 2 Diabetes: Exploratory Analyses From the Action for Health in Diabetes Brain Magnetic Resonance Imaging Study
P50
Q33561550-32A173BB-215D-4F90-ADA2-83E723F0DB95Q33906177-5FF7A141-A8A1-4FD2-AB94-5580CFBB0D1FQ33975467-B4FA58E9-008F-489F-8D67-47A1685F3D6AQ34071045-89A33353-BC5C-427B-B14F-E59D6AF9F511Q34615661-8C83EE86-D99F-4931-9015-CD546779C299Q35195840-7B63CCCC-F00F-4169-8159-D854C1BB8A89Q36223361-F687C648-2494-43E6-BD35-39C031162566Q36475295-767AB587-998D-4059-B3FA-71D5E8DA2E39Q37177003-CAAE6A33-98E0-456B-9D02-8E5ADF68A5F6Q37199294-939D60D7-C833-4D52-9FCE-003BC7B219FFQ37319974-143327AA-390D-4646-BC7F-0193187E709FQ37669734-C345C32D-A2C5-4287-B4A0-6DC054B68DD6Q37687037-7545A807-3C9E-4AC3-8CED-7C939A17757AQ40190946-275E2110-1071-499A-BA89-A0A8ED81F12DQ50721674-ED3EBF82-CEDB-4D3A-AB96-B7C14ACFFE38Q50997782-6044BC68-7168-4286-8353-6C77EFA58216Q51945741-BF691A0C-A9FF-4CC6-A8F8-BC86250D134CQ51981378-4DCFC578-3902-4FF1-8895-03C7F127281EQ53262589-589B58C2-5AFA-4347-838B-46EC6DB86093Q79715573-DE9829A0-2CB4-4B42-8599-926B1CBD8D47Q87124345-CEA4CDD1-7AA0-4812-B8B6-2B1E66737638Q88265451-A4466F4C-12A9-41B4-8094-029DE5C0E2CBQ88541558-5696A445-8102-4B19-825A-A5D224A1514BQ92656269-E7082B5F-5A49-4556-B1B6-ADD14A106881Q93170635-32D21570-97B4-47A2-978D-CD9CEA99DBD2
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-7745-3513
@en
name
Kathleen M Hayden
@ast
Kathleen M Hayden
@en
Kathleen M Hayden
@es
Kathleen M Hayden
@nl
type
label
Kathleen M Hayden
@ast
Kathleen M Hayden
@en
Kathleen M Hayden
@es
Kathleen M Hayden
@nl
prefLabel
Kathleen M Hayden
@ast
Kathleen M Hayden
@en
Kathleen M Hayden
@es
Kathleen M Hayden
@nl
P106
P1153
7003298585
P31
P496
0000-0002-7745-3513